Genezen

Genezen is a technical and quality-focused contract development and manufacturing organization (CDMO) supporting developers of cell and gene therapies. With more than 12 years of experience in cell and gene therapy, the company provides viral vector services and manufacturing solutions designed to help advance programs from preclinical development through GMP supply. Its capabilities cover adeno-associated virus (AAV), lentiviral and retroviral vectors, as well as plasmids and testing.

For AAV programs, Genezen offers platform, process and analytical expertise; its lentiviral support extends from plasmid design and cell line development through manufacturing. The company also provides retroviral vector production using technologies and facilities designed for aseptic manufacturing. Genezen emphasizes collaborative project management, quality, scalability and reproducibility, with testing capabilities intended to help shorten development timelines.

Its facilities in Lexington, Massachusetts, and Fishers, Indiana, include cGMP-compliant and commercially licensed viral vector manufacturing capacity. Through its services, facilities and partnerships, Genezen aims to help therapy developers move discoveries toward clinical and patient applications